Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1111/j.1445-5994.1994.tb02185.x | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Extracorporeal treatment for poisoning to beta-adrenergic antagonists: systematic review and recommendations from the EXTRIP workgroup.
Crit Care
June 2021
Research Center, CIUSSS du Nord-de-L'île-de-Montréal, Hôpital du Sacré-Coeur de Montréal, University of Montreal, Montreal, QC, Canada.
Background: β-adrenergic antagonists (BAAs) are used to treat cardiovascular disease such as ischemic heart disease, congestive heart failure, dysrhythmias, and hypertension. Poisoning from BAAs can lead to severe morbidity and mortality. We aimed to determine the utility of extracorporeal treatments (ECTRs) in BAAs poisoning.
View Article and Find Full Text PDFWe present a patient with end-stage hypertrophic cardiomyopathy who was suffering from ocular and generalized forms of myasthenia gravis as an uncommon neurological complication of sotalol. This case report warns clinicians to maintain caution over rare side effects of medication, which could be confused with the clinical symptoms of the underlying disease.
View Article and Find Full Text PDF[The clinical course of end stage heart disease in 152 patients qualified for heart transplantation in a four year observation].
Przegl Lek
March 2000
Kliniki Choroby Wieńcowej Collegium Medicum Uniwersytetu Jagiellońskiego w Krakowie.
Unlabelled: The aim of the study was to analyse the clinical course of pts with end stage disease (ESD) in the period of four years. The study population consisted of 152 pts (132 males, 20 females) at the age of 17-66 years (mean = 48.8 year SD = 9.
View Article and Find Full Text PDFRecurrent Torsades de Pointes After Sotalol Therapy for Symptomatic Paroxysmal Atrial Fibrillation in a Patient with End-Stage Renal Disease.
J Cardiovasc Pharmacol Ther
April 1999
VA Medical Center West Los Angeles, Los Angeles, California, USA
BACKGROUND: In recent years there has been ain increase in the use of class III antiarrhythmic drugs such as sotalol, amiodarone, and the so-called pure class III compound for the control of cardiac arrhythmias. It appears there has been a corresponding increase in the frequency of torsades de pointes (TdP). METHODS AND RESULTS: The case reported here, a patient on daily renal dialysis for end-stage renal disease, has important implications for class III agents, which are excreted largely by the kidneys.
View Article and Find Full Text PDFRadiofrequency ablation of a fascicular tachycardia after orthotopic cardiac transplantation.
Heart
April 1998
Department of Cardiology, Harefield Hospital, Middlesex, UK.
A 51 year old male received an orthotopic transplant because of end stage ischaemic heart disease. The donor was a healthy male teenager with no history of arrhythmias or other cardiac conditions. The patient presented with haemodynamically stable tachycardia and dyspnoea five weeks post-transplant.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!